Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: J Healthc Qual. 2021 Mar-Apr;43(2):119–125. doi: 10.1097/JHQ.0000000000000281

Figure 2-. Variation in panel size of patients and diabetes screening adherence according to US Preventive Services Task Force (USPSTF) guidelines across 79 primary care clinics.

Figure 2-

Each clinic’s panel size is indicated by the black line, with the percentage of patients who complete diabetes screening by clinic as indicated by the gray diamond. USPSTF diabetes screening adherence was defined by receiving at least 1 screening test (either HbA1C or Fasting Plasma Glucose) during the 3 years prior to their first outpatient encounter date among patients 40-70 years of age who have a body mass index ≥25 kg/m2.